Israel signed a deal with U.S. pharmaceutical company Pfizer on Friday to purchase its coronavirus vaccine and will pay NIS 120 million in advance.
The agreement does not include any commitment by the company to supply the vaccines to Israel, but only an intention to do so "according to the circumstances".
In such a case, a cash advance will be returned, which will be paid to the company as early as next week, Ynet has learned.
The advance, in the amount of NIS 120 million, will be refunded if the company decides not to supply the vaccine doses to Israel.